Phase I study of F16IL2 antibody–cytokine fusion with very low‐dose araC in acute myeloid leukaemia relapse after allogeneic stem cell transplantation
2008 ◽
Vol 14
(2)
◽
pp. 61
2009 ◽
Vol 21
(Suppl 1)
◽
pp. S35-S37
◽
2009 ◽
Vol 145
(2)
◽
pp. 262-264
◽
2016 ◽
Vol 98
(2)
◽
pp. 160-168
◽
2017 ◽
Vol 86
◽
pp. 233-239
◽
2012 ◽
Vol 158
(5)
◽
pp. 666-668
◽